コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ho are at too high of a risk to undergo open heart surgery.
2 life that patients usually experience after heart surgery.
3 of the past year's literature on congenital heart surgery.
4 eterization performed early after congenital heart surgery.
5 ications and outcomes in patients after open-heart surgery.
6 e complications and one-year mortality after heart surgery.
7 less than one year of age who underwent open-heart surgery.
8 ly, this may result in completely endoscopic heart surgery.
9 botic technology for totally endoscopic open heart surgery.
10 erative factors for children undergoing open heart surgery.
11 edated in the intensive care unit after open heart surgery.
12 ivery in the first 24 hours after congenital heart surgery.
13 rain in a cohort of neonates undergoing open-heart surgery.
14 e detected preoperatively in patients having heart surgery.
15 dy may be improving outcome after congenital heart surgery.
16 procedure in infants who had undergone open heart surgery.
17 ients aged 60 years or older undergoing open-heart surgery.
18 factors into ischemic myocardium during open-heart surgery.
19 supplementation in children undergoing open-heart surgery.
20 days) versus placebo immediately after open heart surgery.
21 nital heart defects continue to require open-heart surgery.
22 range of operative procedures in congenital heart surgery.
23 provision (inhaled NO) before and after open heart surgery.
24 was defined as a history of heart attack or heart surgery.
25 hypertension, and atrial scars from previous heart surgery.
26 lation and decrease hospital stay after open heart surgery.
27 placement, and cannulation of the aorta for heart surgery.
28 butamine, a drug commonly administered after heart surgery.
29 artery bypass graft surgery and/or valvular heart surgery.
30 tive period for patients undergoing valvular heart surgery.
31 (CS) was measured in 32 patients during open heart surgery.
32 accident victims, and 2 patients undergoing heart surgery.
33 ongly promote thrombus formation during open heart surgery.
34 ients in the postoperative period after open heart surgery.
35 n the early postoperative period after right heart surgery.
36 cardioplegia on blood component usage after heart surgery.
37 iated with adverse outcomes after congenital heart surgery.
38 nisolone in subpopulations undergoing infant heart surgery.
39 ing complications after pediatric congenital heart surgery.
40 ental outcomes or HRQOL 12 months after open heart surgery.
41 onged and severe stress when undergoing open heart surgery.
42 rovide analgesia during and after congenital heart surgery.
43 Patients with cCHD who underwent infant open heart surgery.
44 condition worsens after pediatric congenital heart surgery.
45 the cardiopulmonary bypass oxygenator during heart surgery.
46 l outcomes in neonates undergoing congenital heart surgery.
47 (n=32) and without AF (n=30) during elective heart surgery.
48 level and adverse outcomes after congenital heart surgery.
49 on (FTR) is often left untreated during left heart surgery.
50 st common operations performed in congenital heart surgery.
51 y outcomes in children undergoing congenital heart surgery.
52 thetic valve degeneration involves redo open-heart surgery.
53 ler unit water tanks to patients during open-heart surgery.
54 th to 9 years duration) were studied at open heart surgery.
55 41) and non-DM (n = 37) patients undergoing heart surgery.
56 rom patients undergoing clinically indicated heart surgery.
57 population but not among patients undergoing heart surgery.
58 ostoperative management following congenital heart surgery.
59 in morbidity and mortality after congenital heart surgery.
60 in children with shock following congenital heart surgery.
61 mellitus, renal failure, and history of open heart surgery.
62 lantation of a prosthetic valve without open heart surgery.
63 malities among infants undergoing reparative heart surgery.
64 in the unstretched valves despite sham open heart surgery.
65 , and morbid events after complex congenital heart surgery.
66 surgeons without specialization in pediatric heart surgery.
67 to influence early outcomes after congenital heart surgery.
68 rare but devastating complication following heart surgery.
69 ngenital heart disease before they underwent heart surgery.
70 enhance the long-term success of congenital heart surgeries.
71 .0%), pericardial complications (1.4%), open heart surgery (0.2%), and postoperative respiratory fail
72 stent and LSP AF in patients undergoing open heart surgery (1) to test the hypothesis that persistent
74 for pancreatic resection, 138 for pediatric heart surgery, 195 for repair of abdominal aortic aneury
75 inimum caseload: craniotomy (33%), pediatric heart surgery (25%), repair of abdominal aortic aneurysm
77 (n=482) had a higher frequency of prior open heart surgery (44.0%) than patients from Ohio (n=6046) (
78 to >15 years' duration) were studied at open heart surgery, 8 before and 1 during cardiopulmonary byp
79 nents and procedure-related Adult Congenital Heart Surgery (ACHS) score, identify additional risk fac
80 erse outcome with CABG, including prior open-heart surgery, age >70 years, left ventricular ejection
82 id and accurate in predicting ARF after open-heart surgery; along with increasing its clinical utilit
83 ch is employed, which requires multiple open-heart surgeries and significant attendant morbidity and
84 on the atria of patients at the time of open heart surgery and brought out through the anterior chest
85 een STAT3 and miR-21 that is activated after heart surgery and can contribute to atrial fibrillation.
87 ionwide population-based study on congenital heart surgery and catheter-based interventions, unbiased
88 /- 43 mg/day) started 24 to 48 h before open heart surgery and continued for four days postoperativel
89 injury occurs commonly following congenital heart surgery and is associated with adverse outcomes.
90 hrombotic and bleeding complications of open heart surgery and is produced by cleavage of prothrombin
91 detomidine is commonly used after congenital heart surgery and may be associated with a decreased inc
93 ased interventions, with elimination of open heart surgery and new electronic devices enabling, for e
95 nges in key metabolites following congenital heart surgery and to examine the potential of metabolic
96 t transfusion practices following congenital heart surgery are showing promise in reducing donor expo
101 A total of 33,217 patients underwent open-heart surgery at the Cleveland Clinic Foundation (1993 t
102 patients (63 +/- 9.1 years) undergoing open-heart surgery at the San Diego Veterans Administration H
104 evaluation of quality of care in congenital heart surgery based on the complexity of the surgical pr
105 onstruction typically involves multiple open-heart surgeries because all existing graft materials hav
106 performed within six weeks after congenital heart surgery between August 1995 and January 2001 were
107 frequency of atrial fibrillation after open-heart surgery but the effectiveness of oral amiodarone i
108 g the incidence of atrial fibrillation after heart surgery, but did not significantly alter length of
110 mics in children with shock after congenital heart surgery, but the adverse effects of the therapy in
111 ease have been given a new chance at life by heart surgery, but the potential for neurological injury
116 At the time of ICU admission after open heart surgery, clinical criteria are evident that highli
117 nants of health and outcomes post-congenital heart surgery, clinical risk models typically exclude th
118 heart surgeries from locally held Congenital Heart Surgery Collaborative for Longitudinal Outcomes an
119 18 years using the New York State Congenital Heart Surgery Collaborative for Longitudinal Outcomes an
120 ims from the CHS-COLOUR (New York Congenital Heart Surgery Collaborative for Longitudinal Outcomes an
122 alternative to one of the foundational open-heart surgeries currently performed to treat single-vent
124 the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) will begin voluntary p
125 ined Society of Thoracic Surgeons Congenital Heart Surgery Database at Lurie Children's Hospital.
126 the Society for Thoracic Surgeons Congenital Heart Surgery Database between 2010 and 2019, NIT was as
127 the Society of Thoracic Surgeons Congenital Heart Surgery Database between January 1, 2010, and Dece
130 The Society of Thoracic Surgeons Congenital Heart Surgery Database or the New York State Pediatric C
131 the Society of Thoracic Surgeons Congenital Heart Surgery Database to evaluate rates of postoperativ
132 the Society of Thoracic Surgeons-Congenital Heart Surgery Database to examine associations between s
133 the Society of Thoracic Surgeons Congenital Heart Surgery Database who underwent cardiac surgery bet
135 ith congenital heart disease undergoing open-heart surgery, de novo variants were associated with wor
136 Prolonged critical illness after congenital heart surgery disproportionately harms patients and the
138 vere MR are turned down for traditional open heart surgery due to frailty and other existing co-morbi
139 ents presenting with an ACS who undergo open-heart surgery during the same hospitalization is associa
140 ical management of heart failure, early open heart surgery (endocardectomy and valve repair/replaceme
141 eart transplantation after failed congenital heart surgery, especially after failed single-ventricle
142 d surgical data available and underwent open-heart surgery exclusive of heart transplantation as thei
143 clusion does not add significant harm during heart surgery for another indication, but evidence on st
144 logic outcomes following neonatal and infant heart surgery for complex congenital heart lesions.
147 developed Risk Stratification for Congenital Heart Surgery for ICD-10 Administrative Data (RACHS-2) m
148 enoxaparin (n=151) before proceeding to open heart surgery for urgent therapy during the same hospita
149 inical data were obtained for all congenital heart surgeries from locally held Congenital Heart Surge
151 hort time period, mortality after congenital heart surgery has been reduced substantially in Guatemal
157 US News & World Report list of top heart and heart surgery hospitals performed on acute myocardial in
159 ith symptomatic aortic stenosis without open-heart surgery; however, the benefits are mitigated by th
160 cell cultures from patients undergoing open heart surgery, human atrial fibroblasts, atrial cardiomy
162 underwent coronary artery bypass or valvular heart surgery in 43 Department of Veterans Affairs medic
163 atients aged >16 years undergoing congenital heart surgery in a large tertiary center between 2003 an
164 as) frequently complicate recovery from open heart surgery in children and can be difficult to manage
165 se of CA to support vital organs during open heart surgery in infancy is associated, at the age of 4
167 LP-1 agonist exenatide during and after open-heart surgery in reducing the risk of death and major or
169 in 13 of 15 patients (87%) after congenital heart surgery, in the posterior subannular region of the
171 sks associated with pediatric reconstructive heart surgery include injury of the sinoatrial node (SAN
172 cember 2006 through April 2008) in the major heart surgery intensive care unit (MHS-ICU) of our insti
175 on of the median sternotomy wound after open heart surgery is a devastating complication associated w
178 vels at 24 hours, 7 days, and 3 months after heart surgery is concomitant with some traits of inflamm
179 d-crystalloid cardioplegia in pediatric open heart surgery is dependent on age and degree of cyanosis
181 mental outcomes in children who undergo open heart surgery is hampered by the absence of a suitable c
183 cidence of tachyarrhythmias after congenital heart surgery, it may be associated with increased odds
184 of the approach in pediatric reconstructive heart surgery may reduce risks of injuring nodal tissues
185 ars (median Risk adjustment after congenital heart surgery Model for Outcome Surveillance in Australi
187 rwent early intervention (188 [25%] had open heart surgery, most commonly coronary artery bypass graf
188 and at least one of five risk factors (prior heart surgery, myocardial infarction within seven days,
189 h >=moderate-severe chronic AR without prior heart surgery, myocardial infarction, or overt coronary
190 lled trial in which patients undergoing open-heart surgery (n=220, average age 73 years) received ami
192 set, created by the International Congenital Heart Surgery Nomenclature and Database Project, are now
198 Conventional devices require invasive open-heart surgery or less invasive endovascular surgery, bot
200 iogenic shock (OR, 3.07; 95% CI, 1.90-4.96), heart surgery (OR, 3.04; 95% CI, 2.26-4.08), cardiopulmo
201 iology); myocardial preservation during open-heart surgery; organ preservation for transplantation; a
202 al strategies to improve national congenital heart surgery outcomes and reduce variability across hos
205 or postoperative complications of congenital heart surgery patients is essential to enable prompt ini
206 maera infections were diagnosed in 2012 in 2 heart surgery patients on extracorporeal circulation.
207 tudy comparing case-patients (n=5) with open heart surgery patients without subsequent sternotomy sit
208 the past two decades, advances in congenital heart surgery, pediatric cardiology, and intensive care
209 the last two decades advances in congenital heart surgery, pediatric cardiology, and pediatric inten
212 available Risk Stratification for Congenital Heart Surgery (RACHS-2) tool for ICD-10 administrative d
213 pe of surgery (Risk Adjustment in Congenital Heart Surgery [RACHS-1] category), center, and center vo
215 -2 system captured 99.6% of total congenital heart surgery registry cases, with 1.0% false positives.
217 nths and weighting 22+/-4 kg, underwent open heart surgery replicating a nontransannular approach to
220 adjusting for Risk Adjustment for Congenital Heart Surgery risk category, premature birth, major nonc
221 there is no published method for congenital heart surgery risk stratification for administrative dat
222 f disease severity (Risk Adjusted Congenital heart surgery score-1, Pediatric Logistic Organ Dysfunct
223 h groups with no cases of conversion to open heart surgery, second valve implantation within the firs
224 th: eight [0.6%] of 1320; conversion to open heart surgery: six [0.5%] of 1319) and similar to native
225 ation for Cardio-Thoracic Surgery Congenital Heart Surgery (STAT) mortality category, age, gestationa
228 In children undergoing complex congenital heart surgery, the optimal postoperative glucose range m
230 es associated with corrective and palliative heart surgery to antenatal and preoperative factors gove
231 of the heart in a young canine model of open heart surgery to control 2 common postoperative supraven
234 other complications compared with MPN (open heart surgery to repair cardiac laceration [6 versus 0],
235 ng of chronic AF in patients undergoing open heart surgery to test the hypothesis that chronic AF is
236 ntions (TCIs) are performed after congenital heart surgery to treat residual or recurrent anatomic le
237 actors for poor outcome, including age, open heart surgery, tricuspid insufficiency (TI), cardiac rhy
238 sequelae continue to occur in neonates after heart surgery using deep hypothermic cardiopulmonary byp
239 re studied immediately before and after open heart surgery using simultaneous LA pressure measurement
240 The presence of CON regulations for open heart surgery was ascertained from the National Director
241 f cardiac arrest in infants after congenital heart surgery was better than that for pediatric intensi
243 k of procedural complications requiring open heart surgery was significantly higher in the bicuspid v
244 vital organ support strategy used in infant heart surgery was total circulatory arrest (CA) or low-f
245 rge cohort of patients undergoing congenital heart surgery, we examined for an association between de
246 l analysis of children undergoing congenital heart surgery, we were unable to demonstrate a significa
247 zed fashion, 118 patients who underwent open heart surgery were assigned to right atrial pacing at 45
248 n younger than 2 years undergoing congenital heart surgery were randomized between July 2017 and Apri
249 ee hundred patients undergoing standard open heart surgery were randomized in a double-blind fashion
250 n 34.5+/-44.1 months of age) undergoing open-heart surgery were selected to either alpha-stat (n=51)
251 enting with ACS may be sent directly to open heart surgery while still on anticoagulation, it is impo
252 ed decline in mortality following congenital heart surgery, while important, also has resulted in an
253 ril 2005 including 1,084 patients undergoing heart surgery who were admitted into the fast-track unit
254 s now increasingly used following congenital heart surgery with a low associated incidence of organ f
255 nvolving infants (<1 year of age) undergoing heart surgery with cardiopulmonary bypass at 24 sites pa
256 acceptably high risk for mortality from open heart surgery with cardiopulmonary bypass in the setting
257 ether they improve outcomes in infants after heart surgery with cardiopulmonary bypass is unknown.
259 ut hypoxic stress (cyanosis) undergoing open heart surgery with cold-crystalloid cardioplegia were in
260 ants younger than 2 years who underwent open heart surgery with CPB for congenital heart disease.
261 ertificate-of-need (CON) regulation for open heart surgery with higher hospital coronary artery bypas
263 dren (age, 5.4 +/- 2.1 years) and after open-heart surgery without allograft implantation in 11 age-m